CHIRON DIAGNOSTICS ACS: 180 CARBAMAZEPINE ASSAY— 510(k) K964765

Substantially Equivalent

Chiron Diagnostics Corp.

FDA 510(k) clearance K964765 for CHIRON DIAGNOSTICS ACS: 180 CARBAMAZEPINE ASSAY, Substantially Equivalent on 1997-02-14. Applicant: Chiron Diagnostics Corp..

Clearance details

Applicant: Chiron Diagnostics Corp.
Product code: Code KLT
Advisory panel: Clinical Toxicology
Date received: 1996-11-27
Decision date: 1997-02-14
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Medfield, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.